Alzheimer's Research Studies

The Human Spatial Cognition Lab at the University of Arizona (UA) is recruiting adult volunteers to participate in research investigating memory and spatial navigation.

The AHEAD Study is a new trial aiming to prevent Alzheimer’s disease. It is evaluating whether an investigational treatment (BAN2401 (lecanemab)) can lower the amount of amyloid in the brain and how that impacts decline in memory loss due to Alzheimer’s.

Studies have shown that changes caused by Alzheimer’s occur in the brain many years before a person shows symptoms of the disease.

The Alzheimer Prevention Trials Webstudy (APT Webstudy) is an online memory and thinking research tool aiming to accelerate the enrollment for Alzheimer’s clinical trials. This will be done by identifying and tracking individuals who may be at higher risk for developing Alzheimer’s, with the goal of providing members the opportunity to participate in clinical trials aimed at preventing dementia. 

CARE (Collaborative Approach for Asian Americans, Native Hawaiians and Pacific Islanders Research and Education) is creating a research registry of Asian Americans, Native Hawaiians and Pacific Islanders (AANHPI) who are interested in participating in various types of research, particularly those related to Alzheimer's disease and related dementias (ADRD), aging, caregiving, and other factors that affect health across the lifespan.

CarePRO Virtual Plus is a research project designed to assist individuals caring for someone with memory loss by providing education and skill-training sessions designed to reduce stress, enhance well-being, manage challenges, and plan for the future.

EPIC II (Early-Stage Partners in Care) is a research project designed to assist people with early-stage memory loss and their care partners by providing early-stage related education and skill-training sessions designed to reduce stress, enhance well-being, manage challenges, and plan for the future. Researchers will gather feedback from individuals about their experience to continue to improve programs for early-stage memory loss.